Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GOLIMUMAB for Psoriasis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 447 adverse event reports in the FDA FAERS database where GOLIMUMAB was used for Psoriasis.

Most Reported Side Effects for GOLIMUMAB

Side Effect Reports % Deaths Hosp.
Drug ineffective 17,959 25.9% 1,184 3,397
Rheumatoid arthritis 12,272 17.7% 1,719 3,342
Pain 11,443 16.5% 1,581 2,876
Fatigue 9,626 13.9% 1,701 2,679
Off label use 8,764 12.7% 1,664 3,186
Alopecia 8,394 12.1% 1,526 2,425
Rash 8,331 12.0% 1,757 2,685
Joint swelling 8,264 11.9% 1,729 2,722
Arthralgia 7,968 11.5% 1,535 2,875
Abdominal discomfort 7,902 11.4% 1,533 2,410
Drug intolerance 7,802 11.3% 1,250 2,351
Contraindicated product administered 7,732 11.2% 1,049 2,182
Swelling 7,713 11.1% 1,689 2,436
Systemic lupus erythematosus 7,635 11.0% 1,753 2,344
Pemphigus 7,438 10.8% 1,578 2,149

Other Indications for GOLIMUMAB

Rheumatoid arthritis (31,947) Product used for unknown indication (20,273) Ankylosing spondylitis (5,530) Psoriatic arthropathy (5,477) Colitis ulcerative (3,637) Prostatic specific antigen (848) Crohn's disease (726) Juvenile idiopathic arthritis (331) Arthritis (300) Axial spondyloarthritis (295)

Other Drugs Used for Psoriasis

APREMILAST (76,127) SECUKINUMAB (58,471) ADALIMUMAB (56,634) RISANKIZUMAB-RZAA (40,890) ETANERCEPT (30,483) USTEKINUMAB (21,763) IXEKIZUMAB (16,569) GUSELKUMAB (11,736) CERTOLIZUMAB PEGOL (8,179) METHOTREXATE (6,628)

Related Pages

GOLIMUMAB Full Profile All Psoriasis Drugs GOLIMUMAB Demographics GOLIMUMAB Timeline